Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Schnipper: Update in Oncology. (0.25 sec) 

[PDF] Update in Oncology


LE Schnipper, A Sandler, R Gray, MC … - Annals of Internal …, 2007 - Am Coll Physicians
T his Update in Oncology reviews the most important articles relevant to oncology that were published
in 2006. The Table summarizes changes to clinical practice that should emerge from these
articles. They reflect im- provement in the use of standard chemotherapy for ovarian and ...
Related articles - All 4 versions

[CITATION] How two studies on cancer screening led to two results


HG Welch, S Woloshin, LM Schwartz - New York Times, 2007
Cited by 2 - Related articles

Should patients with ovarian cancer receive intraperitoneal chemotherapy …


C Runowicz - Nature Clinical Practice Oncology, 2006 - nature.com
CD Runowicz gained her medical degree in 1977 from Jefferson Medical College. Currently,
Dr Runowicz is Director of the Neag Comprehensive Cancer Center at the University of Connecticut
Health Center. She has published more than 100 papers and is a recognized leader in ...
Cited by 2 - Related articles - BL Direct - All 3 versions

Intraperitoneal chemotherapy for ovarian cancer: a complex strategy but what an …


DM Provencher, DM Provencher - Bull Cancer, 2006 - john-libbey-eurotext.fr
Au Canada, on estime à 2 400 le nombre de nouveaux cas de cancer de l'ovaire et le nombre
de décès attribuables à cette maladie s'est élevé à 1 550 l'an dernier. Actuellement, les traitements
optimaux pour soigner le cancer de l'ovaire comprennent la chirurgie agressive, la ...
Cited by 2 - Related articles - All 3 versions

[CITATION] Intraperitoneal chemotherapy in the treatment of ovarian cancer


JJ Kavanagh - Seminars in Surgical Oncology - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 1 - Related articles - BL Direct - All 2 versions

Intraperitoneal chemotherapy in patients with nodal metastasis


JL Walker - Gynecologic Oncology, 2006 - Elsevier
Most complications of surgery were resolved prior to IP chemotherapy in this study. Participants
received their first cycle of chemotherapy on an average of 25 days following their surgery, and
had recovered by this time. The presence of adhesions, asymptomatic infections, or ...
Cited by 1 - Related articles - All 2 versions

Intraperitoneal chemotherapy for frontline ovarian cancer therapy: Vindicated or …


RL Coleman - Current Oncology Reports, 2006 - Springer
Introduction: Advanced ovarian cancer is a disease char- acterized by diffuse intraperitoneal
metastatic spread. Despite this presentation, contemporary management consisting of surgery
and postoperative adjuvant che- motherapy induces clinical remission in the majority of ...
Related articles - All 2 versions

La chimiothérapie intrapéritonéale pour traiter le cancer de l'ovaire: une stratégie …


DM Provencher - Bull Cancer, 2006 - john-libbey-eurotext.fr
A u Canada, on estime à 2 400 le nombre de nouveaux cas de cancer de l'ovaire et le nombre
de décès attribuables à cette maladie s'est élevé à 1 550 l'an dernier. Actuellement, les traitements
optimaux pour soigner le cancer de l'ovaire comprennent la chirurgie agressive, la ...
Related articles - All 3 versions

Intraperitoneal chemotherapy for women with advanced epithelial ovarian …


EL Trimble, MC Christian - Gynecologic Oncology, 2006 - Elsevier
In this issue of Gynecologic Oncology, Dr. Joan Walker and her colleagues report the Gynecologic
Oncology Group (GOG) experience with intraperitoneal (IP) catheters in GOG 172, a phase III
randomized trial comparing intravenous (IV) chemotherapy to a combination of IV and IP ...
Cited by 10 - Related articles - All 2 versions

[PDF] Intraperitoneal therapy for stage III optimally debulked ovarian cancer


SJ Tucker - cancer, 2006 - communityoncology.net
Should women with optimally resected stage III ovarian cancer be treated with intraperitoneal
(IP) cisplatin and a taxane rather than the universally accepted standard of care—a combination
of intravenous (IV) carboplatin and paclitaxel? Three randomized clinical trials, the most ...
Related articles - View as HTML


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google